Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pancreatitis

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 83 articles:
HTML format



Single Articles


    July 2021
  1. PANDANABOYANA S
    Exploring Koch's postulate for SARS-CoV-2-induced acute pancreatitis: is it all about the ACE?
    Br J Surg. 2021 Jul 6. pii: 6316026. doi: 10.1093.
    PubMed    


    June 2021
  2. HUGHES DL, Hughes A, White PB, Silva MA, et al
    Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes.
    Br J Surg. 2021 Jun 28. pii: 6310415. doi: 10.1093.
    PubMed    


  3. WENIGER M, Hank T, Qadan M, Ciprani D, et al
    Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.
    Br J Surg. 2021;108:709-716.
    PubMed     Abstract available


  4. OBA A, Wu YHA, Lieu CH, Meguid C, et al
    Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study.
    Br J Surg. 2021 Jun 22. pii: 6307483. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  5. SCHNEIDER M, Hackert T, Strobel O, Buchler MW, et al
    Technical advances in surgery for pancreatic cancer.
    Br J Surg. 2021 May 27. pii: 6287225. doi: 10.1093.
    PubMed     Abstract available


  6. LAYTON GR, Chung WY, Isherwood J, Fraser RE, et al
    Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units.
    Br J Surg. 2021 May 17. pii: 6277144. doi: 10.1093.
    PubMed    


  7. MARCHEGIANI G, Bassi C
    Prevention, prediction, and mitigation of postoperative pancreatic fistula.
    Br J Surg. 2021 May 4. pii: 6263467. doi: 10.1093.
    PubMed    


    April 2021
  8. KOSTI A, Rybinski B, Javanmard-Emamghissi H, Laing R, et al
    Protocol letter: multicentre prospective cohort study of the early management of acute pancreatitis in Great Britain and Ireland: PANC Study (Pancreatitis: A National Cohort Study).
    Br J Surg. 2021 Apr 12. pii: 6224208. doi: 10.1093.
    PubMed    


    March 2021
  9. HEIDSMA CM, Engelsman AF, van Dieren S, Stommel MWJ, et al
    Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA).
    Br J Surg. 2021 Mar 30. pii: 6202974. doi: 10.1093.
    PubMed    


  10. LATENSTEIN AEJ, Mackay TM, van der Geest LGM, van Eijck CHJ, et al
    Effect of centralization and regionalization of pancreatic surgery on resection rates and survival.
    Br J Surg. 2021 Mar 19. pii: 6178575. doi: 10.1093.
    PubMed     Abstract available


  11. RICCI C, Partelli S, Landoni L, Rinzivillo M, et al
    Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis.
    Br J Surg. 2021 Mar 16. pii: 6173849. doi: 10.1093.
    PubMed     Abstract available


  12. VAN ROESSEL S, Janssen BV, Soer EC, Farina Sarasqueta A, et al
    Scoring of tumour response after neoadjuvant therapy in resected pancreatic cancer: systematic review.
    Br J Surg. 2021;108:119-127.
    PubMed     Abstract available


  13. BI F, Qian Y, Song L, Qu H, et al
    Genome sequencing of pancreatic cancer: differential expression by location.
    Br J Surg. 2021;108:e67-e68.
    PubMed    


  14. OBA A, Inoue Y, Ono Y, Ishizuka N, et al
    Staging laparoscopy for pancreatic cancer using intraoperative ultrasonography and fluorescence imaging: the SLING trial.
    Br J Surg. 2021;108:115-118.
    PubMed    


  15. RAU KM, Chang CS, Pei SN, Hsieh MC, et al
    Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
    Br J Surg. 2021 Mar 12. pii: 6168654. doi: 10.1093.
    PubMed    


  16. YAMADA S, Fujii T, Satoi S
    Author's reply: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis (Br J Surg 2020; 107: 1811-1817).
    Br J Surg. 2021 Mar 6. pii: 6161217. doi: 10.1093.
    PubMed    


    February 2021
  17. PAUSCH TM, Mitzscherling C, Aubert O, Liu X, et al
    Applying an intraoperative predictive indicator for postoperative pancreatic fistula: randomized preclinical trial.
    Br J Surg. 2021 Feb 20. pii: 6145318. doi: 10.1093.
    PubMed     Abstract available


  18. STEPHENS JR, Wong JLC, Broomhead R, Stumpfle R, et al
    Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis.
    Br J Surg. 2021 Feb 4. pii: 6128540. doi: 10.1093.
    PubMed    


    January 2021
  19. YAMADA S, Fujii T, Satoi S
    Author response to: Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
    Br J Surg. 2021;108:e56.
    PubMed    


  20. YADAV T, Kurdia K, Irrinki S
    Intraperitoneal paclitaxel for pancreatic cancer with peritoneal metastasis.
    Br J Surg. 2021;108:e55.
    PubMed    


  21. YU X
    Comment on: Acute pancreatitis in a COVID-19 patient.
    Br J Surg. 2021;108:e48.
    PubMed    


  22. HIPP J, Hussung S, Timme-Bronsert S, Boerries M, et al
    Perioperative cell-free mutant KRAS dynamics in patients with pancreatic cancer.
    Br J Surg. 2021 Jan 26. pii: 6120257. doi: 10.1093.
    PubMed    


  23. WENNERBLOM J, Ateeb Z, Jonsson C, Bjornsson B, et al
    Reinforced versus standard stapler transection on postoperative pancreatic fistula in distal pancreatectomy: multicentre randomized clinical trial.
    Br J Surg. 2021 Jan 20. pii: 6104783. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  24. BALZANO G, Falconi M
    Author response to: Modelling centralization of pancreatic surgery: some additional considerations.
    Br J Surg. 2020 Oct 13. doi: 10.1002/bjs.12056.
    PubMed    


  25. GIANOTTI L
    Modelling centralization of pancreatic surgery: some additional considerations.
    Br J Surg. 2020 Oct 13. doi: 10.1002/bjs.12057.
    PubMed    


  26. BHORIWAL S, Kumar S, Mishra A, Kumar N, et al
    Comment on: Randomized clinical trial of pancreaticogastrostomy versus pancreaticojejunostomy on the rate and severity of pancreatic fistula after pancreaticoduodenectomy.
    Br J Surg. 2020 Oct 10. doi: 10.1002/bjs.12045.
    PubMed    


  27. SALVIA R, Marchegiani G
    Evolving management of pancreatic cystic neoplasms.
    Br J Surg. 2020;107:1393-1395.
    PubMed    


    September 2020
  28. WENIGER M, Hank T, Qadan M, Ciprani D, et al
    Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.
    Br J Surg. 2020 Sep 30. doi: 10.1002/bjs.12003.
    PubMed     Abstract available


    August 2020
  29. ZHANG H, Yin TY, Qin RY
    Challenges and Measures in Prevention of Nosocomial Infection of COVID-19 During Resumption of Work: Experience from a Pancreatic Surgery Department, Wuhan, China.
    Br J Surg. 2020 Aug 24. doi: 10.1002/bjs.11943.
    PubMed    


    July 2020
  30. CHIARELLO MM, Cariati M, Brisinda G
    Assessment of severity of acute pancreatitis in a Sars-CoV-2 pandemia.
    Br J Surg. 2020 Jul 20. doi: 10.1002/bjs.11818.
    PubMed     Abstract available


  31. YAMADA S, Fujii T, Yamamoto T, Takami H, et al
    Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
    Br J Surg. 2020 Jul 7. doi: 10.1002/bjs.11792.
    PubMed     Abstract available


    June 2020
  32. BALZANO G, Guarneri G, Pecorelli N, Paiella S, et al
    Modelling centralization of pancreatic surgery in a nationwide analysis.
    Br J Surg. 2020 Jun 27. doi: 10.1002/bjs.11716.
    PubMed     Abstract available


  33. ROMPIANESI G, Shankar S, Reddy S, Silva M, et al
    Caught in the crossfire: hepato-bilio-pancreatic cancer surgery in the midst of COVID-19.
    Br J Surg. 2020 Jun 22. doi: 10.1002/bjs.11764.
    PubMed    


  34. MIAO Y, Lidove O, Mauhin W
    First case of acute pancreatitis related to SARS-CoV-2 infection.
    Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11741.
    PubMed    


    May 2020
  35. LIU ZW, Yang SZ, Wang PF, Feng J, et al
    Minimal-access retroperitoneal pancreatic necrosectomy for infected necrotizing pancreatitis: a multicentre study of a step-up approach.
    Br J Surg. 2020 May 25. doi: 10.1002/bjs.11619.
    PubMed     Abstract available


    April 2020
  36. SPINELLI A, Pellino G, Danese S
    Author response to: Covid-19-related pancreatic injury.
    Br J Surg. 2020 Apr 30. doi: 10.1002/bjs.11648.
    PubMed    


  37. MUKHERJEE R, Smith A, Sutton R
    Covid-19-related pancreatic injury.
    Br J Surg. 2020 Apr 30. doi: 10.1002/bjs.11645.
    PubMed    


  38. ANAND ER, Major C, Pickering O, Nelson M, et al
    Acute pancreatitis in a COVID-19 patient.
    Br J Surg. 2020 Apr 27. doi: 10.1002/bjs.11657.
    PubMed    


    January 2020
  39. DELAYRE T, Guilbaud T, Resseguier N, Mamessier E, et al
    Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoing resection.
    Br J Surg. 2020 Jan 21. doi: 10.1002/bjs.11434.
    PubMed     Abstract available


  40. SCHULZ C, Schirra J, Mayerle J
    Indications for endoscopic retrograde cholangiopancreatography and cholecystectomy in biliary pancreatitis.
    Br J Surg. 2020;107:11-13.
    PubMed    


    December 2019
  41. UMANS DS, Hallensleben ND, Verdonk RC, Bouwense SAW, et al
    Recurrence of idiopathic acute pancreatitis after cholecystectomy: systematic review and meta-analysis.
    Br J Surg. 2019 Dec 25. doi: 10.1002/bjs.11429.
    PubMed     Abstract available


    November 2019
  42. TUNG S, Coburn NG, Davis LE, Mahar AL, et al
    Population-based study of the prevalence and management of self-reported high pain scores in patients with non-resected pancreatic adenocarcinoma.
    Br J Surg. 2019;106:1666-1675.
    PubMed     Abstract available


  43. IMAMURA T, Yamamoto Y, Sugiura T, Okamura Y, et al
    Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer.
    Br J Surg. 2019;106:1649-1656.
    PubMed     Abstract available


    October 2019
  44. GROEN JV, Tummers WS, Mieog JS, Swijnenburg RJ, et al
    Author response to: Resection margin status in pancreatic cancer surgery: is it really less important than the N status?
    Br J Surg. 2019;106:1559-1560.
    PubMed    


  45. FIORILLO C, Quero G, Alfieri S
    Resection margin status in pancreatic cancer surgery: is it really less important than the N status?
    Br J Surg. 2019;106:1559.
    PubMed    


    August 2019
  46. TANAKA M, Mihaljevic AL, Probst P, Heckler M, et al
    Meta-analysis of recurrence pattern after resection for pancreatic cancer.
    Br J Surg. 2019 Aug 27. doi: 10.1002/bjs.11295.
    PubMed     Abstract available


  47. KIRKEGARD J, Mortensen FV
    Author response to: It is time for a biological definition of locally advanced pancreatic cancer.
    Br J Surg. 2019;106:1257-1258.
    PubMed    


  48. DEL CHIARO M, Schulick RD
    It is time for a biological definition of locally advanced pancreatic cancer.
    Br J Surg. 2019;106:1257.
    PubMed    


    July 2019
  49. MOODY N, Adiamah A, Yanni F, Gomez D, et al
    Meta-analysis of randomized clinical trials of early versus delayed cholecystectomy for mild gallstone pancreatitis.
    Br J Surg. 2019 Jul 3. doi: 10.1002/bjs.11221.
    PubMed     Abstract available


    June 2019
  50. KIM YI, Song KB, Lee YJ, Park KM, et al
    Management of isolated recurrence after surgery for pancreatic adenocarcinoma.
    Br J Surg. 2019;106:898-909.
    PubMed     Abstract available


    March 2019
  51. TUMMERS WS, Groen JV, Sibinga Mulder BG, Farina-Sarasqueta A, et al
    Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.
    Br J Surg. 2019 Mar 18. doi: 10.1002/bjs.11115.
    PubMed     Abstract available


  52. KIRKEGARD J, Aahlin EK, Al-Saiddi M, Bratlie SO, et al
    Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation.
    Br J Surg. 2019 Mar 4. doi: 10.1002/bjs.11093.
    PubMed     Abstract available


    February 2019
  53. HANNA-SAWIRES RG, Groen JV, Klok FA, Tollenaar RAEM, et al
    Outcomes following pancreatic surgery using three different thromboprophylaxis regimens.
    Br J Surg. 2019 Feb 18. doi: 10.1002/bjs.11103.
    PubMed     Abstract available


  54. STRIJKER M, Chen JW, Mungroop TH, Jamieson NB, et al
    Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer.
    Br J Surg. 2019 Feb 13. doi: 10.1002/bjs.11111.
    PubMed     Abstract available


  55. UCHIDA Y, Masui T, Nakano K, Yogo A, et al
    Clinical and experimental studies of intraperitoneal lipolysis and the development of clinically relevant pancreatic fistula after pancreatic surgery.
    Br J Surg. 2019 Feb 6. doi: 10.1002/bjs.11075.
    PubMed     Abstract available


  56. WU JM, Kuo TC, Chen HA, Wu CH, et al
    Randomized trial of oral versus enteral feeding for patients with postoperative pancreatic fistula after pancreatoduodenectomy.
    Br J Surg. 2019;106:190-198.
    PubMed     Abstract available


    January 2019
  57. HUTTNER FJ, Capdeville L, Pianka F, Ulrich A, et al
    Systematic review of the quantity and quality of randomized clinical trials in pancreatic surgery.
    Br J Surg. 2019;106:23-31.
    PubMed     Abstract available


    October 2018
  58. DEL CHIARO M, Soreide K
    Trials and tribulations of neoadjuvant therapy in pancreatic cancer.
    Br J Surg. 2018;105:1387-1389.
    PubMed    


    August 2018
  59. MARCHEGIANI G, Andrianello S, Morbin G, Secchettin E, et al
    Importance of main pancreatic duct dilatation in IPMN undergoing surveillance.
    Br J Surg. 2018 Aug 14. doi: 10.1002/bjs.10948.
    PubMed     Abstract available


    July 2018
  60. MARKAR SR, Brodie B, Chin ST, Romano A, et al
    Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer.
    Br J Surg. 2018 Jul 18. doi: 10.1002/bjs.10909.
    PubMed     Abstract available


    May 2018
  61. HANK T, Hinz U, Tarantino I, Kaiser J, et al
    Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Br J Surg. 2018 May 8. doi: 10.1002/bjs.10842.
    PubMed     Abstract available


    April 2018
  62. VERSTEIJNE E, Vogel JA, Besselink MG, Busch ORC, et al
    Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.
    Br J Surg. 2018 Apr 30. doi: 10.1002/bjs.10870.
    PubMed     Abstract available


  63. SCHINDL M, Fugger R, Gotzinger P, Langle F, et al
    Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy.
    Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10840.
    PubMed     Abstract available


    March 2018
  64. KEANE MG, Shamali A, Nilsson LN, Antila A, et al
    Risk of malignancy in resected pancreatic mucinous cystic neoplasms.
    Br J Surg. 2018;105:439-446.
    PubMed     Abstract available


  65. RAOOF M, Ituarte PHG, Woo Y, Warner SG, et al
    Propensity score-matched comparison of oncological outcomes between laparoscopic and open distal pancreatic resection.
    Br J Surg. 2018 Mar 1. doi: 10.1002/bjs.10747.
    PubMed     Abstract available


    January 2018
  66. SENDA Y, Shimizu Y, Natsume S, Ito S, et al
    Randomized clinical trial of duct-to-mucosa versus invagination pancreaticojejunostomy after pancreatoduodenectomy.
    Br J Surg. 2018;105:48-57.
    PubMed     Abstract available


  67. DREYER SB, Jamieson NB, Upstill-Goddard R, Bailey PJ, et al
    Defining the molecular pathology of pancreatic body and tail adenocarcinoma.
    Br J Surg. 2018;105:e183-e191.
    PubMed     Abstract available


    October 2017
  68. ROBERTS KJ
    Improving outcomes in patients with resectable pancreatic cancer.
    Br J Surg. 2017;104:1421-1423.
    PubMed    


    August 2017
  69. RAVIKUMAR R, Sabin C, Abu Hilal M, Al-Hilli A, et al
    Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer.
    Br J Surg. 2017 Aug 22. doi: 10.1002/bjs.10580.
    PubMed     Abstract available


  70. VAN DER GEEST LGM, Lemmens VEPP, de Hingh IHJT, van Laarhoven CJHM, et al
    Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.
    Br J Surg. 2017 Aug 22. doi: 10.1002/bjs.10602.
    PubMed     Abstract available


  71. GREEN R, Charman SC, Palser T
    Early definitive treatment rate as a quality indicator of care in acute gallstone pancreatitis.
    Br J Surg. 2017 Aug 9. doi: 10.1002/bjs.10578.
    PubMed     Abstract available


    June 2017
  72. SIRIWARDENA AK, O'Reilly DA
    Improving care for patients with pancreatitis.
    Br J Surg. 2017 Jun 27. doi: 10.1002/bjs.10585.
    PubMed    


    May 2017
  73. AHOLA R, Siiki A, Vasama K, Vornanen M, et al
    Effect of centralization on long-term survival after resection of pancreatic ductal adenocarcinoma.
    Br J Surg. 2017 May 18. doi: 10.1002/bjs.10560.
    PubMed     Abstract available


    April 2017
  74. LIU T, Huang W, Szatmary P, Abrams ST, et al
    Accuracy of circulating histones in predicting persistent organ failure and mortality in patients with acute pancreatitis.
    Br J Surg. 2017 Apr 24. doi: 10.1002/bjs.10538.
    PubMed     Abstract available


    March 2017
  75. PROBST P, Haller S, Bruckner T, Ulrich A, et al
    Prospective trial to evaluate the prognostic value of different nutritional assessment scores in pancreatic surgery (NURIMAS Pancreas).
    Br J Surg. 2017 Mar 30. doi: 10.1002/bjs.10525.
    PubMed     Abstract available


  76. HUTTNER FJ, Probst P, Knebel P, Strobel O, et al
    Meta-analysis of prophylactic abdominal drainage in pancreatic surgery.
    Br J Surg. 2017 Mar 20. doi: 10.1002/bjs.10505.
    PubMed     Abstract available


  77. BIRD NT, Elmasry M, Jones R, Psarelli E, et al
    Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy.
    Br J Surg. 2017;104:328-336.
    PubMed     Abstract available


    February 2017
  78. TARANTINO I, Warschkow R, Hackert T, Schmied BM, et al
    Staging of pancreatic cancer based on the number of positive lymph nodes.
    Br J Surg. 2017 Feb 14. doi: 10.1002/bjs.10472.
    PubMed     Abstract available


  79. ANSARI D, Bauden M, Bergstrom S, Rylance R, et al
    Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma.
    Br J Surg. 2017 Feb 8. doi: 10.1002/bjs.10471.
    PubMed     Abstract available


    January 2017
  80. UEMURA K, Satoi S, Motoi F, Kwon M, et al
    Randomized clinical trial of duct-to-mucosa pancreaticogastrostomy versus handsewn closure after distal pancreatectomy.
    Br J Surg. 2017 Jan 23. doi: 10.1002/bjs.10458.
    PubMed     Abstract available


    October 2016
  81. STROBEL O, Brangs S, Hinz U, Pausch T, et al
    Incidence, risk factors and clinical implications of chyle leak after pancreatic surgery.
    Br J Surg. 2016 Oct 20. doi: 10.1002/bjs.10316.
    PubMed     Abstract available


  82. PARTELLI S, Cirocchi R, Crippa S, Cardinali L, et al
    Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms.
    Br J Surg. 2016 Oct 5. doi: 10.1002/bjs.10312.
    PubMed     Abstract available


    September 2016
  83. HARTWIG W, Gluth A, Hinz U, Koliogiannis D, et al
    Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
    Br J Surg. 2016 Sep 30. doi: 10.1002/bjs.10221.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: